Assessing the Impact of Rilonacept on Lipid Profiles in Patients With Recurrent Pericarditis
Saved in:
| Main Authors: | Aqieda Bayat, MD, Ankit Agrawal, MD, Ashwin Kumar, MD, Muhammad Majid, MD, Beni Verma, MD, Abdullah Yesilyaprak, MD, Allan L. Klein, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | JACC: Advances |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772963X24007178 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expanding the Patient Pool for Rilonacept
by: Emma St. John, MD, et al.
Published: (2025-07-01) -
A Comprehensive Clinical Evaluation of Rilonacept in the Treatment of Recurrent Pericarditis: A Systematic Review
by: Yu Y, et al.
Published: (2025-08-01) -
Comprehensive Clinical Analysis of Rilonacept in the Treatment of Cryopyrin-Associated Periodic Syndromes: A Systematic Review
by: Zhang T, et al.
Published: (2025-05-01) -
Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (Anakinra)
by: E. L. Nasonov, et al.
Published: (2023-03-01) -
Comparative Efficacy and Safety of Colchicine and Anti–Interleukin‐1 Agents in Recurrent Pericarditis: A Pairwise and Network Meta‐Analysis of Randomized Controlled Trials
by: Muhammad Ehsan, et al.
Published: (2025-07-01)